These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 19730973)
1. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes. Wiik A Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in ANCA-associated vasculitis. Wiik AS Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245 [TBL] [Abstract][Full Text] [Related]
3. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease. Savige J; Trevisin M; Pollock W J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145 [TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis]. Wada T Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859 [TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Csernok E; Lamprecht P; Gross WL Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659 [TBL] [Abstract][Full Text] [Related]
7. What you should know about PR3-ANCA. An introduction. Wiik A Arthritis Res; 2000; 2(4):252-4. PubMed ID: 11094436 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness. Avery TY; Bons J; van Paassen P; Damoiseaux J Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270 [TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic approach to ANCA-associated vasculitides. Gaffo AL Rheum Dis Clin North Am; 2010 Aug; 36(3):491-506. PubMed ID: 20688246 [TBL] [Abstract][Full Text] [Related]
11. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen. Yamanishi Y; Ito-Ihara T; Nagao T; Uno K; Kobayashi S; Muso E; Shane PY; Firestein GS; Hashimoto H; Okazaki T; Suzuki K Mod Rheumatol; 2013 Sep; 23(5):963-71. PubMed ID: 23085883 [TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Radice A; Bianchi L; Sinico RA Autoimmun Rev; 2013 Feb; 12(4):487-95. PubMed ID: 22921790 [TBL] [Abstract][Full Text] [Related]
14. L28. Relevance of detection techniques for ANCA testing. Elena C Presse Med; 2013 Apr; 42(4 Pt 2):582-4. PubMed ID: 23474049 [TBL] [Abstract][Full Text] [Related]